This proposed study is a competing renewal of a study on the nutritional status of HIV-positive and HIV-negative injection drug users (IDU) (NIDA-DA10252). Results from the first year of this 2.5 year grant indicate that serum antioxidant vitamins were similar between HIV-positive and HIV-negative IDUs. However, those HIV-positive participants on antiretroviral combination therapies (ART) including a protease inhibitor (PI) had significantly higher mean serum levels of several antioxidant vitamins compared to both HIV-negatives and HIV-positives not taking PI's. This difference was not explained by differences in dietary intake or supplement use. These results suggest that oxidative stress, as measured by serum antioxidants, may be reduced in patients taking PI's; however, this requires further investigation. Specifically, we would like to examine the associations between oxidative stress and serum antioxidant levels among HIV-negative IDUs and HIV-positive IDUs on various ART regimens. We will also examine the effect of oxidative stress and serum antioxidant levels on HIV disease progression. Furthermore, we have the opportunity to characterize a group of more active IDUs, many of whom are not on ART, with respect to oxidative stress and antioxidant status. The proposed renewal will build on the existing study (TANG - The ALIVE Nutrition Group) and the infrastructure of the ongoing ALIVE study (NIDA-DA04334). In addition to the subjects already enrolled in TANG (n=398), we plan to enroll 52 additional HIV-positive ALIVE participants to increase the sample size of each ARV therapy group to 50; 100 HIV-positive subjects who report injecting drugs at least 3 times a week, who have recently been recruited into the ALIVE study; and 30 HIV negative never-drug using volunteers from the community. Study participants will undergo dietary intake interviews, body composition measurements, and venipuncture for serum measures of oxidative stress and antioxidants. Participants will be followed for HIV-related outcomes for up to four years. The results from this observational study may help to guide the design of more effective interventions of antioxidant supplementation in the era of PI's.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA010252-07
Application #
6522966
Study Section
Special Emphasis Panel (ZRG1-AARR-6 (01))
Program Officer
Khalsa, Jagjitsingh H
Project Start
1996-09-25
Project End
2004-08-31
Budget Start
2002-09-01
Budget End
2004-08-31
Support Year
7
Fiscal Year
2002
Total Cost
$135,534
Indirect Cost
Name
Tufts University
Department
Public Health & Prev Medicine
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02111
Gibbons, Carly J; Carroll, Kathleen M; Ball, Samuel A et al. (2010) Community program therapist adherence and competence in a motivational interviewing assessment intake session. Am J Drug Alcohol Abuse 36:342-9
Martino, Steve; Ball, Samuel A; Nich, Charla et al. (2009) Informal discussions in substance abuse treatment sessions. J Subst Abuse Treat 36:366-75
Martino, Steve; Ball, Samuel; Nich, Charla et al. (2009) Correspondence of motivational enhancement treatment integrity ratings among therapists, supervisors, and observers. Psychother Res 19:181-93
Martino, Steve; Ball, Samuel A; Nich, Charla et al. (2008) Community program therapist adherence and competence in motivational enhancement therapy. Drug Alcohol Depend 96:37-48
Santa Ana, Elizabeth J; Martino, Steve; Ball, Samuel A et al. (2008) What is usual about ""treatment-as-usual""? Data from two multisite effectiveness trials. J Subst Abuse Treat 35:369-79
Martino, Steve; Haeseler, Frederick; Belitsky, Richard et al. (2007) Teaching brief motivational interviewing to Year three medical students. Med Educ 41:160-7
Smit, E; Crespo, C J; Semba, R D et al. (2006) Physical activity in a cohort of HIV-positive and HIV-negative injection drug users. AIDS Care 18:1040-5
Dancheck, Barbara; Tang, Alice M; Thomas, Ann M et al. (2005) Injection drug use is an independent risk factor for iron deficiency and iron deficiency anemia among HIV-seropositive and HIV-seronegative women. J Acquir Immune Defic Syndr 40:198-201
Semba, Richard D; Martin, Barbara K; Kempen, John H et al. (2005) The impact of anemia on energy and physical functioning in individuals with AIDS. Arch Intern Med 165:2229-36
Smit, Ellen; Semba, Richard D; Pilibosian, Erin et al. (2005) Body habitus in a cohort of HIV-seropositive and HIV-seronegative injection drug users. AIDS Patient Care STDS 19:19-30

Showing the most recent 10 out of 16 publications